相关实验视频

Updated: Jun 23, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K

用免疫疗法作为新辅助疗法用于肝移植接受者肝细胞癌的免疫疗法

Maen Abdelrahim1,2,3, Abdullah Esmail1, Mukul K Divatia4

  • 1Section of GI Oncology, Department of Medical Oncology, Houston Methodist Neal Cancer Center, Houston Meth-Odist Hospital, Houston, TX 77030, USA.

Journal of clinical medicine
|June 19, 2024
PubMed
概括

新辅助性免疫检查点抑制剂 (ICPI) 在接受肝移植 (OLT) 的患者中成功降低肝细胞癌 (HCC) 的阶段. 这种方法促进了安全有效的OLT,证明了移植瘤学有前途的结果.

关键词:
米兰标准是米兰标准.肝细胞癌是肝细胞癌.免疫疗法 免疫疗法肝脏移植 肝脏移植 肝脏移植 肝脏移植这是一种新辅助剂.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

409
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.3K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511